Ubs Group Ag Legend Biotech Corp Call Options Transaction History

Ubs Group Ag

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	SELL	$39.5 - $57.22 $541,150 - $783,914	-13,700 Reduced 40.41%	20,200 $894,000
Q1 2024 May 13, 2024	BUY	$55.06 - $69.99 $1.18 Million - $1.5 Million	21,400 Added 171.2%	33,900 $1.9 Million
Q4 2023 Feb 09, 2024	SELL	$57.25 - $69.74 $2.43 Million - $2.96 Million	-42,500 Reduced 77.27%	12,500 $752,000
Q3 2023 Nov 09, 2023	BUY	$63.16 - $76.5 $3.47 Million - $4.21 Million	55,000 New	55,000 $3.69 Million

216

77.9M

412K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.59B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.